nedaplatin has been researched along with pirarubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagawa, Y; Nakashima, T; Shigehara, K; Shimamura, M | 1 |
| Katayanagi, K; Kitagawa, Y; Kurumaya, H; Nakashima, T; Shigehara, K; Shimamura, M | 1 |
2 other study(ies) available for nedaplatin and pirarubicin
| Article | Year |
|---|---|
Squamous cell carcinoma of the bladder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Routes; Female; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Organoplatinum Compounds; Remission Induction; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Vincristine | 2006 |
[Squamous cell carcinoma of the bladder treated with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine--second case report in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cystectomy; Doxorubicin; Drug Administration Routes; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Organoplatinum Compounds; Remission Induction; Urinary Bladder Neoplasms; Vincristine | 2007 |